Nutex Health (NUTX) legal chief exercises RSUs and withholds shares for taxes

Rhea-AI Filing Summary

Nutex Health Inc. Chief Legal Officer-Healthcare Pamela W. Montgomery reported routine equity compensation activity. She exercised restricted stock units that convert into common stock on a one-for-one basis, resulting in the issuance of 2,084 shares of common stock, of which 776 shares were delivered to cover tax withholding obligations.

After these transactions, Montgomery directly held 2,679 shares of common stock. She was also granted 1,525 restricted stock units on March 11, 2026, scheduled to vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

Insider Trade Summary

1,525 shares exercised/converted

Mixed 3 txns

Insider Montgomery Pamela W.

Role Chief Legal Officer-Healthcare

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	1,525	$0.00	--
Exercise	Common Stock	2,084	$0.00	--
Tax Withholding	Common Stock	776	$86.2224	$67K

Holdings After Transaction: Restricted Stock Units — 5,217 shares (Direct); Common Stock — 3,455 shares (Direct)

Footnotes (1)

1. Restricted stock units that convert into common stock on a one-for-one basis upon vesting. Of the 2,084 shares issued subsequent to vesting, 776 shares were sold to cover tax withholding obligations. On March 11, 2026, the Reporting Person was granted 1,525 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Montgomery Pamela W.

(Last) (First) (Middle)

1776 YORKTOWN STREET

SUITE 700

(Street)

HOUSTON TX 77056

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Nutex Health Inc. [ NUTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Officer-Healthcare

3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/10/2026		M		2,084(1)	A	$0(1)	3,455	D
Common Stock	03/10/2026		F		776(2)	D	$86.2224	2,679	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0(1)	03/10/2026		M		1,525(1)		03/01/2027(3)	03/01/2029(3)	Common Stock	1,525	$0	5,217	D

Explanation of Responses:

1. Restricted stock units that convert into common stock on a one-for-one basis upon vesting.

2. Of the 2,084 shares issued subsequent to vesting, 776 shares were sold to cover tax withholding obligations.

3. On March 11, 2026, the Reporting Person was granted 1,525 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

	/s/ Pamela Montgomery	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Nutex Health (NUTX) report for Pamela W. Montgomery?

The filing shows Pamela W. Montgomery exercised restricted stock units into 2,084 common shares. Of these, 776 shares were used to satisfy tax withholding obligations, with the remaining shares added to her direct common stock holdings.

How many Nutex Health (NUTX) shares does Pamela W. Montgomery hold after the Form 4 transactions?

After the reported transactions, Pamela W. Montgomery directly holds 2,679 shares of Nutex Health common stock. This figure reflects the net position following the RSU-related share issuance and the tax-withholding share disposition.

Were Pamela W. Montgomery’s Nutex Health (NUTX) transactions open-market buys or sells?

No open-market buys or sells are reported. The Form 4 describes an exercise or conversion of restricted stock units and a related tax-withholding disposition, where 776 shares were delivered to cover tax obligations rather than sold on the market.

What new equity award did Pamela W. Montgomery receive from Nutex Health (NUTX)?

On March 11, 2026, Pamela W. Montgomery was granted 1,525 restricted stock units. These RSUs vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029, each convertible one-for-one into common stock upon vesting.

What does the tax-withholding transaction mean in the Nutex Health (NUTX) Form 4?

The Form 4 shows a code F transaction where 776 common shares were delivered to cover tax withholding obligations. This represents a tax-withholding disposition, not an open-market sale, and is a standard mechanism tied to equity compensation vesting.

What role does Pamela W. Montgomery hold at Nutex Health (NUTX) in this Form 4?

In the filing, Pamela W. Montgomery is identified as an officer of Nutex Health, serving as Chief Legal Officer-Healthcare. The reported transactions relate to her equity-based compensation in that executive capacity, involving restricted stock units and common stock.